ShareValue scores for VALIANTLAB.NSE: Valuation 69, Quality 30, Growth 45, Health 39.

VALIANTLAB.NSE
NSE

Valiant Laboratories Limited

₹61.52(+0.47%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

3% to 18%
Valuation
69
Fair Value
Price vs Value
Quality
30
Weak
Business Strength
Growth
45
Moderate
Revenue & Earnings
Health
39
Stressed
Financial Stability
Momentum
54
Neutral
Price Trend

Company Details

About

Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopoeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also offers specialty chemicals. The company was formerly known as Bharat Chemicals and changed its name to Valiant Laboratories Limited in August 2021. The company was founded in 1980 and is based in Mumbai, India. Valiant Laboratories Limited is a subsidiary of Dhanvallabh Ventures LLP.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026